Proposed German drug pricing legislation is causing investment cuts and expansion cancellations for pharmaceutical companies.

The entities involved

• Boehringer Ingelheim →

  German pharmaceutical company

  • Sheila Denton was appointed as General Counsel & Corporate Secretary at Boehringer Ingelheim.Mon 15:03
  • Boehringer Ingelheim and Palatin Technologies reported $13.2 million in revenue from their Fiscal 2026 collaboration.Mon 13:31
• Eli Lilly and Company →

  American pharmaceutical company

  • ExxonMobil, Berkshire Hathaway, and Eli Lilly are top holdings in the Avantis ETF.Mon 17:18
  • The FDA approved Olumiant for pediatric indications on September 1, 2026.Mon 05:59
• AstraZeneca →

  British-Swedish pharmaceutical company

  • AstraZeneca's trial failure has created a competitive advantage for Alnylam Pharmaceuticals, which is leveraging AI in its commercial execution.Mon 11:04
  • Pharmaceutical companies are adopting AI for clinical data gathering, product promotion, and prototyping.Sat 18:52